feed,title,long_url,short_url
Benzinga,"Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab",https://benzinga.com/general/biotech/22/02/25338021/biogen-exercises-option-to-participate-developing-genentechs-bispecific-antibody-mosunetuzumab,https://bit.ly/3KXo6am
Benzinga,Mid-Morning Market Update: Markets Mostly Lower Following Monday's Rally; UPS Earnings Top Views,https://benzinga.com/news/earnings/22/02/25339596/mid-morning-market-update-markets-mostly-lower-following-mondays-rally-ups-earnings-top-views,https://bit.ly/3uipIph
Benzinga,Becton Dickinson Strengthens Post-Treatment Monitoring For Blood Cancers With Cytognos Acquisition,https://benzinga.com/m-a/22/02/25337281/becton-dickinson-strengthens-post-treatment-monitoring-for-blood-cancers-with-cytognos-acquisition,https://bit.ly/3gbst3z
Benzinga,Lockheed Martin Names Jay Malave As Finance Chief,https://benzinga.com/news/22/02/25338043/lockheed-martin-names-jay-malave-as-finance-chief,https://bit.ly/3GdHWuh
